Contact Information: Rapture Biotech D-201, Sector - 10, Noida Uttar Pradesh. Phone , ,

Size: px
Start display at page:

Download "Contact Information: Rapture Biotech D-201, Sector - 10, Noida Uttar Pradesh. Phone , ,"

Transcription

1 Topics Covered: MODULE 1 Introduction To Pharmacovigilance Terminologies used in Pharmacovigilance ADRs Polypharmacy MODULE 2 Pharmacoepidemiology Iatrogenesis Prescription-event monitoring MODULE 3 SAE Paradoxical effect MODULE 4 Adverse Event Reporting Adverse Event Reporting Requirements 4 Elements of AE case Coding of AE Seriousness determination MODULE 5 Introduction to Signal Detection and Data Mining Mining spontaneous reporting system data

2 Clinical versus computational approaches MODULE 6 Premarketing Clinical Safety and Pharmacovigilance Importance of premarketing clinical safety and pharmacovigilance to ensure Good Pharmacovigilance Practice MODULE 7 Postmarketing Drug Safety and Pharmacovigilance Components of a Good Postmarketing Report MODULE 8 Pharmacovigilance reporting methods- Expedited reporting, Clinical Trial Reporting, Spontaneous reporting, Aggregate Reporting Risk management Causality Assessment MODULE 9 Pharmacovigilance In India The specific aims of the Pharmacovigilance Programmers Improving methods Practical difficulties Causes Of Failure Of Implementation Of Pharmacovigilance In India MODULE 10 Current Problems In Pharmacovigilance Future Aspect Of Pharmacovigilance In India

3 MODULE 11 Live Project

4 Table of Content S.No. Course/Topic Form No. Of Hours Required 1 Introduction To Pharmacovigilance L, P 15 2 Pharmacoepidemiology L, P 15 3 SAE L 15 4 AE reporting L, P 15 5 Introduction to Signal Detection and Data Mining L, P 15 6 Premarketing Clinical Safety and Pharmacovigilance L, P 15 7 Postmarketing Drug Safety and Pharmacovigilance L, P 15 8 Pharmacovigilance reporting methods L, P 15 9 Pharmacovigilance In India L, P Current Problems and Future Aspect Of Pharmacovigilance In India L, P Live project Pc 30 Abbreviations- L- Lecture P- Presentation Pc- Practical

5 Salient Features: Pharmacovigilance is the discipline which takes care of such aspects and is concerned with identifying, validating, quantifying and evaluating adverse reactions associated with the use of drugs thereby improving the safety of medicines in use. This introductory course provides an overview of pharmacovigilance across a spectrum of topics, presenting both US and global perspectives. You will learn the basic concepts, regulatory requirements, and recent trends and approaches, to understanding and communicating a safety profile. The objective is to develop candidates who are experts at monitoring the adverse effects of the drugs which have been released in the market. Course Objectives: Certificate course is a skill development program designed to cover all aspects of Pharmacovigilance and drug safety management. It sensitizes the students and equips them with knowledge on Pharmacovigilance practices worldwide and on the Indian scenario in detail. This course gives young executives an opportunity to remain ahead of competitors in a very nascent yet competitive environment. The prime objective is to provide a high-end training thereby enhancing the employment prospects of the participants. Course Outcome: On the successful completion of this course, a Certificate in Pharmacovigilance will be awarded. Career Prospects: The number of career opportunities continues to grow in this field. The Pharmaceutical industry in India is valued at Rs. 90,000 crore and is growing at the rate of % per annum. India is rapidly emerging as a hub of Global Clinical trials and a destination for Drug Discovery and Development along with for Pharmacovigilance. New Chemical Entities (NCE), high tech Pharma products, vaccines as well as new dosage forms are being introduced in the country which throws up the challenge of monitoring Adverse Drug Reactions (ADRs) over a large population base. Consequently, the demand for qualified

6 Pharmacovigilance and clinical research specialists has grown significantly with supply at present, not being able to match demand. With the advent of more pharmaceutical companies looking at India for their Pharmacovigilance activities, there is an imminent need to develop good professionals in Pharmacovigilance and there is ardent need of trained professionals in Pharmacovigilance. The Pharmacovigilance Course provides professionals with the specialised knowledge required to help biotechnology, medical device, pharmaceutical and food companies manage the Pharmacovigilance processes. Types of Companies Hiring Pharmacovigilance Professionals: The job opportunities are excellent in the areas of pharmacovigilance, regulatory affairs and quality operations in pharmaceutical, biotech, veterinary, cosmetic, food and medical devices, Contract Research Organisations and government. These professionals will find employment as Pharmacovigilance Manager, Drug Safety Specialist, Regulatory Affairs Associates, Regulatory Affairs Assistants, Quality Assurance Associates, Quality Assurance Investigators, Documentation Officers and Medical Information Associates, Drug Inspectors, Drug Controllers, Regulatory Affairs Consultants for Pharma / Biotechnology Industry, Food Safety Scientist, etc. Employability Enhancement Programme : The Employability Enhancement Programme is a course designed to increase your employability. The competition in the Biotech industry is fierce, moreover good jobs are limited in number. Giving a job interview is a skill in itself. This skill set includes certain aspects of personality development in addition to preparing you for technical and aptitude tests. The programme focuses on four major areas that need attention for an interview. These areas are: Personality development Communication skills Interview skills Aptitude and speaking skills We will also work upon the development of professional skills in you like: Team work Project management Crisis handling This programme is aimed at helping you master the art of giving an interview through a standard job screening process.

2018 SALARY GUIDE. Science & Pharma.

2018 SALARY GUIDE. Science & Pharma. 2018 SALARY GUIDE Science & Pharma www.sigmar.ie SCIENCE & PHARMA In Demand for 2018 Hot Jobs Quality Assurance Specialist/ Qualified Person Quality Control Specialist Validation Specialist Process Scientist

More information

Importance of Pharmacovigilance for Pharmaceutical Industry

Importance of Pharmacovigilance for Pharmaceutical Industry Importance of Pharmacovigilance for Pharmaceutical Industry JARIR AT THOBARI, MD, DPHARM, PHD FACULTY OF MEDICINE GADJAH MADA UNIVERSITY YOGYAKARTA, INDONESIA Role of Pharma Company Globally Investment

More information

KINGSMANN CARE GROUP

KINGSMANN CARE GROUP PHARMA CONSULTANTS KINGSMANN CARE GROUP KINGSMANN CONSULTANCY SERVICES Thank you for taking interest in Kingsmann Consultancy Services. Kingsmann Consultancy (KC) is a leading business development-consulting

More information

Advanced Post Graduate Diploma in Pharmacovigilance & Medical Writing

Advanced Post Graduate Diploma in Pharmacovigilance & Medical Writing Advanced Post Graduate Diploma in Pharmacovigilance & Medical Writing Online Distance & Classroom Weekend Industry Accredited Program Job Oriented 100% Past Placement Record Best Clinical Research & Health

More information

PROCEDURE FOR CONDUCTING PHARMACOVIGILANCE INSPECTIONS REQUESTED BY THE CVMP. Ad Hoc PhV Inspectors Working Group

PROCEDURE FOR CONDUCTING PHARMACOVIGILANCE INSPECTIONS REQUESTED BY THE CVMP. Ad Hoc PhV Inspectors Working Group European Medicines Agency Inspections London, 20 April 2009 EMEA/INS/PhV/85058/2008 Procedure no: INS/PhV-V/2 PROCEDURE FOR CONDUCTING PHARMACOVIGILANCE INSPECTIONS REQUESTED BY THE CVMP Ad Hoc PhV Inspectors

More information

NIS Considerations - Bulgaria

NIS Considerations - Bulgaria NIS Considerations - Bulgaria An overview of the considerations when conducting Noninterventional Studies in Bulgaria Stuart McCully CHCUK Ltd NIS-C-BG-2014 1 Table of Contents Disclaimer 5 Copyright 5

More information

Management in Pharmaceutical Industry

Management in Pharmaceutical Industry Master Program Management: Industrial Management Module: Chemistry for Drug Substances Management in Pharmaceutical Industry Prof. Tatsiana Savitskaya Assoc. Prof. Iryna Kimlenka Lectures 5,6 The Key Aspects:

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MODULE 1 1.2.1 MEDICINES CONTROL COUNCIL APPLICATION FOR REGISTRATION OF A MEDICINE 1 Module 1: Administrative Information Application Form This application form will be included in the South African Common

More information

Career in Biotechnology Industry. Novartis Biocamp Roadshow

Career in Biotechnology Industry. Novartis Biocamp Roadshow Career in Biotechnology Industry Novartis Biocamp Roadshow What is biotechnology? Biotechnology, often referred to as biotech, is the application of biological research techniques to create new processes

More information

Let us join hands with PvPI to ensure patient safety ADR Reporting Helpline (Toll Free):

Let us join hands with PvPI to ensure patient safety ADR Reporting Helpline (Toll Free): Regional Workshop on "Basics of Pharmacovigilance & Establishment of Pharmacovigilance System in Pharmaceutical Industries - A Way Forward" June 23, 2017 - AIIMS, Rishikesh (10:30 AM to 04:00 PM) Last

More information

Insights into Careers in the Pharma Sector

Insights into Careers in the Pharma Sector Eli Lilly Kinsale Insights into Careers in the Pharma Sector UCC Dr Kevin Lydon Eli Lilly SA, Kinsale 12 th May 2014 Eli Lilly Kinsale Manufacturing Who am I? From Westport, Co Mayo Chemistry Degree in

More information

Re: PCIM/11/01 Public Consultation on Implementing Measures for Pharmacovigilance

Re: PCIM/11/01 Public Consultation on Implementing Measures for Pharmacovigilance 07 November 2011 By email: sanco pharmaceuticals@ec.europa.eu Directorate General for Health and Consumers Unit SANCO/D/3 BE 1049 Brussels Belgium Dear Sirs, Re: PCIM/11/01 Public Consultation on Implementing

More information

CAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS

CAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS CAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS How TOPRA can support you as you drive your regulatory career forward ABOUT TOPRA TOPRA (The Organisation for Professionals in Regulatory Affairs)

More information

Advance Topics in Pharmacoepidemiology. Risk Management. Conflict of Interest Declaration. Benefit Harm Profile?

Advance Topics in Pharmacoepidemiology. Risk Management. Conflict of Interest Declaration. Benefit Harm Profile? Advance Topics in Pharmacoepidemiology Risk Management 2012 Mid-Year ISPE Meeting Miami, April 21-23, 2012 Ariel E., Arias MD, PhD - Fac. Pharmacy; Université de Montréal - Biologics & Genetic Therapies

More information

Pharmacovigilance and Patient Safety. Dr M. Roy Jobson Chairperson: Pharmacovigilance Committee of the MCC

Pharmacovigilance and Patient Safety. Dr M. Roy Jobson Chairperson: Pharmacovigilance Committee of the MCC Pharmacovigilance and Patient Safety Dr M. Roy Jobson Chairperson: Pharmacovigilance Committee of the MCC Outline Pharmacovigilance The South African Medicines Control Council (MCC) The National Adverse

More information

EMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9).

EMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9). EMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9). Responsible, under the Head of Unit for the Post-Authorisation Evaluation of Medicinal Products

More information

STRATEGIC RESOURCING. inventivhealthclinical.com

STRATEGIC RESOURCING. inventivhealthclinical.com STRATEGIC RESOURCING inventivhealthclinical.com 1 Table of Contents OVERVIEW 02 STAFFING 03 MOVING UP THE VALUE CHAIN 04 FUNCTIONAL EXPERTISE Biostatistics and Statistical Programming 05 Clinical Monitoring

More information

harmacovigilance A wake up for

harmacovigilance A wake up for harmacovigilance A wake up for lthcare professionals and the publ repared By: Mr. Sagar D. Kadam Asst.Professor & Admin. Officer HSBPVT s GOI College of Pharmacy, Kashti. Tal. Shrigonda, Dist. Ahmednagar.

More information

FDA Requirements 5/16/2011. FDA and new IND regs. Changes on the horizon: CIOMS IX ICH upcoming initiatives

FDA Requirements 5/16/2011. FDA and new IND regs. Changes on the horizon: CIOMS IX ICH upcoming initiatives Session Overview (1) Although the role of the Qualified Person responsible for Pharmacovigilance is mandated by the European legislation, the QPPV is held responsible for the establishment and the maintenance

More information

Pharmacovigilance in Asia: The China Perspectives. Disclaimer

Pharmacovigilance in Asia: The China Perspectives. Disclaimer Pharmacovigilance in Asia: The China Perspectives Rebecca Wang, MD, FRCP, FACC Head, Product Development Drug Safety Operation, Asia Pacific Roche Shanghai Disclaimer The views and opinions expressed in

More information

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets Peptides are used worldwide in medical research. They contribute immensely to the understanding of diseases and have proven to be effective in medicinal products. Today, peptides can be produced at low

More information

New Man International Journal of Multidisciplinary Studies (ISSN: ) Mohd Azhar-Ud-Din Malik Research Scholars Jiwaji Unversity Gwalior (M.

New Man International Journal of Multidisciplinary Studies (ISSN: ) Mohd Azhar-Ud-Din Malik Research Scholars Jiwaji Unversity Gwalior (M. Abstract 8. INDIAN PHARMACEUTICAL INDUSTRIAL CONTRIBUTION AND COMPETITION Mohd Azhar-Ud-Din Malik Research Scholars Jiwaji Unversity Gwalior (M.P) Biotechnology has become a source of earning for many

More information

Regulatory Affairs in Life Science

Regulatory Affairs in Life Science www.topra.org/careers Regulatory Affairs in Life Science Samantha Alsbury, Head of Professional Development, TOPRA ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION What is healthcare

More information

UNIVERSITY OF MUMBAI

UNIVERSITY OF MUMBAI Academic Council 25/05/2011 Item No. 4.71 UNIVERSITY OF MUMBAI Syllabus for Clinical Studies Program: Diploma Course: Post Graduate Diploma in Clinical Studies, Data Management & Medical Writing (Introduced

More information

MPharm programme in Pharmacovigilance and Pharmacoepidemiology

MPharm programme in Pharmacovigilance and Pharmacoepidemiology MPharm programme in Pharmacovigilance and Pharmacoepidemiology Prof Martie S Lubbe Director: Medicine Usage in South Africa Faculty of Health Sciences Medicine Usage in South Africa Research focus has

More information

POLICY POSITION ON NAMING OF BIOTECHNOLOGY-DERIVED THERAPEUTIC PROTEINS. October 31, 2006

POLICY POSITION ON NAMING OF BIOTECHNOLOGY-DERIVED THERAPEUTIC PROTEINS. October 31, 2006 POLICY POSITION ON NAMING OF BIOTECHNOLOGY-DERIVED THERAPEUTIC PROTEINS October 31, 2006 POLICY POSITION ON NAMING OF BIOTECHNOLOGY-DERIVED THERAPEUTIC PROTEINS 1 This is a joint position statement of

More information

Health Canada s NHP Vigilance Activities

Health Canada s NHP Vigilance Activities Health Canada s NHP Vigilance Activities Canadian Health Food Association (CHFA) East October 3, 2013 Scott Sawler Director General Marketed Health Products Directorate Overview NHP Program & MHPD Activities

More information

HOW CAN AN ADAPTIVE TRAINING PROGRAMME SUPPORT CHANGE IN ORGANISATIONAL STRATEGY? Dr Karine Palin

HOW CAN AN ADAPTIVE TRAINING PROGRAMME SUPPORT CHANGE IN ORGANISATIONAL STRATEGY? Dr Karine Palin HOW CAN AN ADAPTIVE TRAINING PROGRAMME SUPPORT CHANGE IN ORGANISATIONAL STRATEGY? Dr Karine Palin Lifelong Learning in the Biomedical Sciences EMBL Heidelberg, Germany - 5-7 Jul 2016 LEGAL NOTICE DISCLAIMER

More information

Saudi FDA Drug Approval Process. Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority

Saudi FDA Drug Approval Process. Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority Saudi FDA Drug Approval Process Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority Objective Describe the drug regulation practice in Saudi Arabia and

More information

Syllabus for M.Pharm Clinical Research Semester II

Syllabus for M.Pharm Clinical Research Semester II Syllabus for M.Pharm Clinical Research Semester II Clinical Research Methodology Paper I MPCR 201 T Scope After Completion of the course students should be able to understand various practical aspects

More information

Risk Management Plan Guidance

Risk Management Plan Guidance 1 / 17 Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Office of Safety Ⅰ, Pharmaceuticals and Medical Devices Agency This English version is intended to be

More information

Pharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA

Pharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA Pharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA 1 2 ND MENA Regulatory Conference On Bioequivalence, Biowaivers, Bioanalysis, Dissolution & Biosimilars

More information

Post Marketing PV AUDIT AND INSPECTION HOSTING. Michael Ramcharan Reumat Consulting Ejaz Butt ZigZag Associates

Post Marketing PV AUDIT AND INSPECTION HOSTING. Michael Ramcharan Reumat Consulting Ejaz Butt ZigZag Associates Post Marketing PV AUDIT AND INSPECTION HOSTING Michael Ramcharan Reumat Consulting Ejaz Butt ZigZag Associates Agenda Background Preparation Conduct Post Audit & Inspection CAPA Management Audit & Inspection

More information

CERTIFICATE IN BIOPHARMACEUTICALS

CERTIFICATE IN BIOPHARMACEUTICALS Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034-2713 Phone: 267.468.8560 Fax: 267.468.8565 CERTIFICATE IN BIOPHARMACEUTICALS and GENERIC DRUGS Temple offers

More information

ACHIEVEMENTS OF CDSCO DURING YEAR

ACHIEVEMENTS OF CDSCO DURING YEAR ACHIEVEMENTS OF CDSCO DURING YEAR 2015-2017 E-Governance E-Governance in CDSCO through SUGAM Portal has been launched. Following activities of CDSCO are presently performed through the Sugam Portal: Import

More information

Diploma (Base Course) in Medicines Development

Diploma (Base Course) in Medicines Development INTRODUCTION The participation in PharmaTrain Project determines the design of the Master in Medicines Development, adapting the syllabus defined in the European project to the current needs of the Spanish

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India)

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) COPY Date : 23-02-2010 News / Story reproduced with thanks:- Stockmarkest.com Indian pharmaceutical industry has

More information

Global Issue & Regulatory Control of Pharmacovigilance System: A Standard Operating Procedure for a New Develop Organization

Global Issue & Regulatory Control of Pharmacovigilance System: A Standard Operating Procedure for a New Develop Organization Global Issue & Regulatory Control of Pharmacovigilance System: A Standard Operating Procedure for a New Develop Organization Rajendra Kr. Songara, Birendra Shrivastava, Deepak M Gupta *, Rajeev K Singla

More information

29 August Dear Sir/Madam:

29 August Dear Sir/Madam: 29 August 2016 Directorate General for Health and Food Safety DG SANTE Unit B4 "Medical products Quality, Safety and Innovation" European Commission F101 08/058 B-1049 Brussels RE: Public consultation

More information

Career Growth Areas in Physiology / Pharmacology

Career Growth Areas in Physiology / Pharmacology Career Growth Areas in Physiology / Pharmacology Magdalena Alonso-Galicia, PhD Pharmacology Department Forest Research Institute, Inc. Jersey City, NJ 1 Career Growth Areas in BioPharma n Pharmaceutical

More information

Pharmacovigilance Practice in Pharmaceutical Industry. From Adverse Event Collection Risk Management

Pharmacovigilance Practice in Pharmaceutical Industry. From Adverse Event Collection Risk Management Pharmacovigilance Practice in Pharmaceutical Industry From Adverse Event Collection Risk Management Hani Mickail, MD Head Global Clinical Safety Operations - Novartis Pharmacovigilance Workshop 23-24 October

More information

PHARMACOVIGILANCE OF VETERINARY MEDICINAL PRODUCTS: MANAGEMENT OF ADVERSE EVENT REPORTS (AERS)

PHARMACOVIGILANCE OF VETERINARY MEDICINAL PRODUCTS: MANAGEMENT OF ADVERSE EVENT REPORTS (AERS) VICH GL24 (PHARMACOVIGILANCE: AERS) October 2007 For implementation at Step 7 PHARMACOVIGILANCE OF VETERINARY MEDICINAL PRODUCTS: MANAGEMENT OF ADVERSE EVENT REPORTS (AERS) Adopted at Step 6 of the VICH

More information

Food and Drug Administration (FDA) 101

Food and Drug Administration (FDA) 101 Food and Drug Administration (FDA) 101 What is the Food and Drug Administration (FDA)? The FDA is an agency within the U.S. Department of Health and Human Services that is responsible for protecting the

More information

PREFACE. Page 3 of 90

PREFACE. Page 3 of 90 Page 2 of 90 PREFACE This is in consonance with the objective of the Drugs & Cosmetics Act 1940 and Rules 1945 there under and other functions of CDSCO wherever applicable. These guidelines are intended

More information

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly

More information

TRAINING, AUDITING, INTERIM MANAGEMENT AND CONSULTANCY

TRAINING, AUDITING, INTERIM MANAGEMENT AND CONSULTANCY GMP SERVICES TRAINING, AUDITING, INTERIM MANAGEMENT AND CONSULTANCY PCS was founded in 1990 with one simple mission: help companies struggling with GMP in achieving regulatory compliance. We have maintained

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POSITION PAPER ON COMPLIANCE WITH PHARMACOVIGILANCE REGULATORY OBLIGATIONS

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POSITION PAPER ON COMPLIANCE WITH PHARMACOVIGILANCE REGULATORY OBLIGATIONS The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 15 November 2001 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POSITION PAPER ON COMPLIANCE

More information

PHARMACOVIGILANCE IN AND EMERGING MARKETS: AN INDUSTRY PERSPECTIVE. Shashidhar Swamy (Head, Pharmacovigilance) Wockhardt limited, Mumbai

PHARMACOVIGILANCE IN AND EMERGING MARKETS: AN INDUSTRY PERSPECTIVE. Shashidhar Swamy (Head, Pharmacovigilance) Wockhardt limited, Mumbai PHARMACOVIGILANCE IN AND EMERGING MARKETS: AN INDUSTRY PERSPECTIVE Shashidhar Swamy (Head, Pharmacovigilance) Wockhardt limited, Mumbai 1 Disclaimer The content expressed in this presentation is solely

More information

From Bench to Bedside. Russ H. Read June 23, 2014

From Bench to Bedside. Russ H. Read June 23, 2014 From Bench to Bedside Russ H. Read June 23, 2014 Talent Required Scientists, clinicians, technicians, chemists, biologists, pharmacologists, toxicologists, research associates, regulatory experts, manufacturing

More information

Vaccine Safety Monitoring, Reporting and Analysis. GBC 2017, Yun Chon, Ph. D

Vaccine Safety Monitoring, Reporting and Analysis. GBC 2017, Yun Chon, Ph. D Vaccine Safety Monitoring, Reporting and Analysis GBC 2017, Yun Chon, Ph. D Disclaimer This presentation is based on my own opinion and is not representing the opinion of International Vaccine Institute.

More information

EudraVigilance Vet. and Pharmacovigilance of vet. Medicinal products in Serbia

EudraVigilance Vet. and Pharmacovigilance of vet. Medicinal products in Serbia EudraVigilance Vet. and Pharmacovigilance of vet. Medicinal products in Serbia Presented by: Vladimir Raketić, DVM, spec; Audit /QM group Ministry of Agriculture, Forestry and Water Managment, Veterinary

More information

The Pharmacovigilance Quality System. What is it?

The Pharmacovigilance Quality System. What is it? The Pharmacovigilance Quality System What is it? by Andy Blackman 12 November 2018 Are you starting to plan your first Marketing Authorisation Application? If yes, now is the time to start developing your

More information

Pharmacovigilance System in India: Industry Perspective

Pharmacovigilance System in India: Industry Perspective Pharmacovigilance System in India: Industry Perspective Dr. Jamal Baig, Global Pharmacovigilance Country Leader, MSD Pharmaceutical Pvt. Ltd., India. Introduction Currently there are 3 major PV guidelines

More information

elearning Catalog DIAglobal.org/eLearning

elearning Catalog DIAglobal.org/eLearning elearning Catalog DIAglobal.org/eLearning Continuing education DIA s Continuing education program has been approved by a wide range of leading accrediting bodies that oversee the awarding of continuing

More information

INTRODUCTION TO PHARMACOVIGILANCE AND REGULATORY AFFAIRS SPRING 2012

INTRODUCTION TO PHARMACOVIGILANCE AND REGULATORY AFFAIRS SPRING 2012 INTRODUCTION TO PHARMACOVIGILANCE AND REGULATORY AFFAIRS SPRING 2012 Course Description: Pharmacovigilance is the science and activities that relate to the detection, monitoring, assessment, understanding

More information

Module VIII- Post-authorisation safety studies

Module VIII- Post-authorisation safety studies Good Vigilance Practice Module VIII- Post-authorisation safety studies 4th Stakeholder Forum Xavier Kurz An agency of the European Union Post-authorisation safety study Any study relating to an authorised

More information

CBA Workshop Series -3 Drug Safety (Pharmacovigilance) and Big Data. Larry Liu TCONNEX Inc.

CBA Workshop Series -3 Drug Safety (Pharmacovigilance) and Big Data. Larry Liu TCONNEX Inc. CBA Workshop Series -3 Drug Safety (Pharmacovigilance) and Big Data Larry Liu TCONNEX Inc. Larry.liu@tconnex.com Drug Safety Drug Safety is about Adverse Drug Reaction or ADR ADR is any unintended and

More information

EU Pharmaceutical law. André den

EU Pharmaceutical law. André den EU Pharmaceutical law André den Exter denexter@bmg.eur.nl @AndredenExter Outline Occasion EU Pharmaceutical law: regulating the pharmaceutical chain What is a Medicine? Clinical Trials Marketing Authorization

More information

Clinical Trials for Biotechnology Medicines

Clinical Trials for Biotechnology Medicines Clinical Trials for Biotechnology Medicines by James A Southern Member of the Clinical Trials Committee of MCC A personal view point August 2007 Bio-Technology 2007 1 Relevant Properties of Biotechnology

More information

Cadila Healthcare Limited 6/7/15

Cadila Healthcare Limited 6/7/15 Cadila Healthcare Limited 6/7/15 About Zydus Cadila Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the

More information

OVERVIEW OF DIRECTIVE 2001/20. Paul Derbyshire. Background & History. Aims of Directive 2001/20

OVERVIEW OF DIRECTIVE 2001/20. Paul Derbyshire. Background & History. Aims of Directive 2001/20 OVERVIEW OF DIRECTIVE 2001/20 Paul Derbyshire Background & History CONDUCT OF TRIALS III/3976/88 (July 1991) ICH/135/95 (January 1997) 2001/20 75/318 Q,S,E Testing Part 4B: GCP 91/507 MEDICINAL PRODUCTS

More information

National Academic Reference Standards (NARS) Pharmacy. January st Edition

National Academic Reference Standards (NARS) Pharmacy. January st Edition National Academic Reference Standards (NARS) Pharmacy January 2009 1 st Edition Table of Contents Introduction to Pharmacy Education 1 National Academic Reference Standards 3 Curriculum Structure 10 Glossary

More information

Strategy Retreat: A five year strategy

Strategy Retreat: A five year strategy Strategy Retreat: A five year strategy 2013-2018 Our mission The Biochemical Society exists for the advancement of the molecular and cellular biosciences, both as an academic discipline and to promote

More information

Orthopaedic Innovation: Bench, Bedside, Bank

Orthopaedic Innovation: Bench, Bedside, Bank Stephen P Makk, MD, MBA A Seth Greenwald, D-Phil (Oxon) Biomedical Engineering Committee American Academy of Orthopaedic Surgeons 1 1 The Patent Process www.uspto.gov 2 2 Patent: A government grant allowing

More information

Cadila Healthcare Limited

Cadila Healthcare Limited Company, Position & Person Profile Cadila Healthcare Limited 6/8/15 About Zydus Cadila Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value

More information

focus Pharmacovigilance Focus

focus Pharmacovigilance Focus focus 2 Pharmacovigilance Is there a difference in perceived practices between innovative and generic industries? Part 1: Analysis of spontaneous reporting practices in innovative and generic companies

More information

Molecular Biotechnology Master Degree Program

Molecular Biotechnology Master Degree Program > APPLIED LIFE SCIENCES MASTER DEGREE PROGRAM: > FULL TIME Molecular Biotechnology Master Degree Program www.fh-campuswien.ac.at MY OCCUPATIONAL FUTURE. Your Career Opportunities BIOTECHNOLOGY IS ONE OF

More information

UK Standards for Pharmacovigilance Departments 2015

UK Standards for Pharmacovigilance Departments 2015 UK Standards for Pharmacovigilance Departments 2015 03 UK Standards for Pharmacovigilance Departments 2015 Introduction 1 European legislation (Directive 2010/84/EU; Regulation (EU) No 1235/2010) requires

More information

Public private partnerships in support to regulatory sciences

Public private partnerships in support to regulatory sciences Public private partnerships in support to regulatory sciences The Innovative Medicines Initiative example M. Chlebus 3 October 2017 www.efpia.eu Summary: Partnering on regulatory sciences Progress much

More information

Table of Contents. Abbreviations and Acronyms Preface Executive Summary... 15

Table of Contents. Abbreviations and Acronyms Preface Executive Summary... 15 TABLE OF CONTENTS 5 Table of Contents Abbreviations and Acronyms... 11 Preface... 14 Executive Summary... 15 Chapter 1. Defining the Bioeconomy... 19 What is a bioeconomy?... 22 Foreseeing the emerging

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Technology Transfer, Academic and Industry Cooperations

Technology Transfer, Academic and Industry Cooperations Technology Transfer, Academic and Industry Cooperations Jake Micallef PhD MBA COO ValiRx plc Visiting lecturer Simfonec Jake.micallef@valirx.com What do they want? Universities Money to fund research and

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org June 6, 2008 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD

More information

Pharmacovigilance Playbook (Part 1 of 2)

Pharmacovigilance Playbook (Part 1 of 2) PHARMACOVIGILANCE AND RISK MANAGEMENT Pharmacovigilance Playbook (Part 1 of 2) Compiled By: Dr. Mufti Suhail Sayeed James Lind Institute www.jliedu.com www.jli.edu.in James Lind Institute www.jliedu.com

More information

BULGARIAN ASSOCIATION FOR DRUG INFORMATION (BADI)

BULGARIAN ASSOCIATION FOR DRUG INFORMATION (BADI) 1 BULGARIAN ASSOCIATION FOR DRUG INFORMATION (BADI) With the kind support from the Medical University - Sofia, organizes its regular autumn course on Pharmaceutical Regulations on the following topics

More information

Job Title: Head, Clinical Science Job Location: Nanjing, China CV to: Wechat:

Job Title: Head, Clinical Science Job Location: Nanjing, China  CV to: Wechat: Job Title: Head, Clinical Science Job Description: As a senior member of the Clinical Development organization, the Head of Clinical Science will supervise a team of staff to lead the clinical development

More information

Establishing Case Quality Metrics The Sciformix experience

Establishing Case Quality Metrics The Sciformix experience Whitepaper Establishing Case Quality Metrics The Sciformix experience Introduction Measurement of case quality in pharmacovigilance is a relatively new development. Before pharmaceutical companies began

More information

R F D. Results Framework Document for Department of Bio-Technology ( )

R F D. Results Framework Document for Department of Bio-Technology ( ) R F D Results Framework Document for Department of Bio-Technology Vision Section 1: Vision, Mission, Objectives and Functions The vision of the department is to create biotechnology tools and technologies

More information

Make a. Real Difference. Career Opportunities at Pall.

Make a. Real Difference. Career Opportunities at Pall. Make a Real Difference Career Opportunities at Pall www.pall.com/careers Join Pall s Winning Team Our business is organized around two broad markets Pall Industrial and Pall Life Sciences. Key markets

More information

Cadila Healthcare Limited

Cadila Healthcare Limited Company, Position & Person Profile Cadila Healthcare Limited 6/8/15 About Zydus Cadila Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value

More information

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety Disclaimer The views and opinions expressed in this presentation are solely those of the presenter and do not necessarily reflect those of Vifor,

More information

Blue Ribbon Panel 8 - Scope of MedDRA. Background

Blue Ribbon Panel 8 - Scope of MedDRA. Background Blue Ribbon Panel 8 - Scope of MedDRA Background MedDRA was developed by ICH as a standardized medical terminology to facilitate sharing of regulatory information internationally for medical products used

More information

Bachem Annual Report 2017

Bachem Annual Report 2017 BACHEM CONSIDERS ENTRE- PRENEURIAL DYNAMISM AND FITNESS, ALONG WITH THE ABILITY AND COURAGE TO CONSTANTLY DEVELOP, TO BE ESSENTIAL PREREQUISITES FOR CONTINUING SUCCESS. 21 BACHEM S STRATEGY As the Pioneering

More information

UNLOCK YOUR POTENTIAL

UNLOCK YOUR POTENTIAL Adding Value, Enhancing Skills UNLOCK YOUR POTENTIAL FOR EXCELLENCE IN BIOTECHNOLOGY Education Partner California, USA Adding Value, Enhancing Skills CENTER of EXCELLENCE for ADVANCED LEARNING in APPLIED

More information

Quality check of spontaneous adverse drug reaction reporting forms of different countries y

Quality check of spontaneous adverse drug reaction reporting forms of different countries y pharmacoepidemiology and drug safety (2010) Published online in Wiley Online Library (wileyonlinelibrary.com).2004 ORIGINAL REPORT Quality check of spontaneous adverse drug reaction reporting forms of

More information

Indian CRAMS players to cram in growth: CARE Ratings

Indian CRAMS players to cram in growth: CARE Ratings January, 2015 Credit Perspective : Indian CRAMS Indian CRAMS players to cram in growth: CARE Ratings CARE Ratings expects Indian Contract Research and Manufacturing Services (CRAMS) players to register

More information

SCOPE Work Package 8 Lifecycle Pharmacovigilance. PSUR/PSUSA and Referral Recommendations

SCOPE Work Package 8 Lifecycle Pharmacovigilance. PSUR/PSUSA and Referral Recommendations PSUR/PSUSA and Referral Recommendations 2016 Contents Acknowledgments 3 1. Introduction 4 1.1 Purpose of the document 4 1.2 Definitions and abbreviations 5 1.3 Attachments 5 1.4 Background 6 1.5 Context

More information

February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees)

February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees) February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees) 18:00-19:30 Hrs Inauguration of the 16 th BioAsia Convention Presentation of Genome Valley Excellence Award 19:30-20:00 Hrs Inauguration

More information

Safety reporting requirements in the post marketing phase. Pharmacovigilance Specialty Committee SQA Conference March 2017 Washington

Safety reporting requirements in the post marketing phase. Pharmacovigilance Specialty Committee SQA Conference March 2017 Washington Safety reporting requirements in the post marketing phase Pharmacovigilance Specialty Committee SQA Conference March 2017 Washington DISCLAIMER These materials have been prepared solely for educational

More information

Let us empower you to be a pharmacovigilance superhero...

Let us empower you to be a pharmacovigilance superhero... Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that can be used for many different pharmacovigilance activities. Pharmacovigilance

More information

Clinical Trials Registry and Good Clinical Practice: an Indian Scenario

Clinical Trials Registry and Good Clinical Practice: an Indian Scenario Additional Professor, & Joint Medical Superintendent, Department of Pharmacology, Postgraduate Institute of Medical Education Research, Chandigarh 160012, India Chandigarh 160012, India Clinical Trials

More information

THE R&D LABORATORY THAT BOOSTS YOUR DEVELOPMENT PROJECTS

THE R&D LABORATORY THAT BOOSTS YOUR DEVELOPMENT PROJECTS THE R&D LABORATORY THAT BOOSTS YOUR DEVELOPMENT PROJECTS CREATED IN 2011 WITH A PROVEN EXPERTISE IN AUDIT AND REGULATORY AFFAIRS, BIOLABEX NORTH AMERICA PARIS EUROPE ASIA EXTENDS ITS OFFERINGS AND IS NOW

More information

Introduction to CMC Regulatory Affairs

Introduction to CMC Regulatory Affairs Introduction to CMC Regulatory Affairs Bharathi Mamidipudi Regulatory Affairs Consultant II Syner-G Pharma Consulting, LLC Northeastern University, Boston November 10, 2016 My Background Experience ~4

More information

FIRST YEAR PHARM. D. Know about the theory and their application in pharmacy PDM107 Remedial Mathematics

FIRST YEAR PHARM. D. Know about the theory and their application in pharmacy PDM107 Remedial Mathematics PDL101 Human Anatomy and Physiology FIRST YEAR PHARM. D Students learn the basic concepts of human organ, location, function, parts with model PDP102 Pharmaceutics Students will be exposed to various dosage

More information

Potential Steps in Active Surveillance

Potential Steps in Active Surveillance Background The Sentinel System will augment FDA s postmarket safety assessment capabilities by enhancing its capacity to conduct active surveillance at the population level. Conducting active surveillance

More information

Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development

Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development No. 1 of 10 1. regulates all the drugs products manufactured and sold in the USA. (A) EMEA (B) IND (C) FDA (D) NDA (E) OSHA

More information

8 th Kitasato- Harvard Symposium

8 th Kitasato- Harvard Symposium 8 th Kitasato- Harvard Symposium CONSISTENT SAFETY RISK MANAGEMENT THROUGH THE PRODUCUT LIFE CYCLE FROM CLINICAL DEVELOPEMNT TO POST APPROVAL - Efforts of Regulatory Authority in Japan - Kaoru Misawa Director,

More information

Pharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life

Pharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life i3l PHARMACY BACHELOR PROGRAM The architect of drugs Improving the Quality of Life Pharmacy Message From the Head of Study Program Pharmaceutical products are essential to support various human health

More information

Syllabus: GS Case Studies in Drug Development. GSBS Large Classroom (BSRB S3.8371) 10:30am- 12:00noon, Mondays Spring 2019 semester.

Syllabus: GS Case Studies in Drug Development. GSBS Large Classroom (BSRB S3.8371) 10:30am- 12:00noon, Mondays Spring 2019 semester. Syllabus: GS13 1111 Case Studies in Drug Development GSBS Large Classroom (BSRB S3.8371) 10:30am- 12:00noon, Mondays Spring 2019 semester Instructor Zhiqiang An, Ph.D. Professor and Robert A. Welch Distinguished

More information